The role of radiotherapy in the management of upper gastrointestinal and hepato-biliary and pancreatic cancers: Current status and future directions

Clinical Oncology

Volumn 26, Issue 9, 2014, Pages 519-521

  Mukherjee, S ^a   Symonds, R P ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN; ERLOTINIB; GEMCITABINE; OXALIPLATIN; PACLITAXEL;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; EDITORIAL; HEPATOBILIARY SYSTEM CANCER; HUMAN; ONCOLOGY; PANCREAS CANCER; PRIORITY JOURNAL; STOMACH CANCER; UPPER GASTROINTESTINAL TRACT; ESOPHAGEAL NEOPLASMS; GALLBLADDER NEOPLASMS; LIVER NEOPLASMS; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS; TRENDS;

ESOPHAGEAL NEOPLASMS; GALLBLADDER NEOPLASMS; HUMANS; LIVER NEOPLASMS; PANCREATIC NEOPLASMS; RADIOTHERAPY; STOMACH NEOPLASMS;

EID: 84905567771     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2014.06.006     Document Type: Editorial

References (19)

1. [Last accessed 06.05.14]. http://www.cancerresearchuk.org/cancer-info/cancerstats/.
2. Bang Y.J., Van Cutsem E., Feyereislova A., et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010, 376(9742):687-697.
3. Conroy T., Desseigne F., Ychou M., et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011, 364(19):1817-1825.
4. Von Hoff D.D., Ervin T., Arena F.P., et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013, 369(18):1691-1703.
5. Urschel J.D., Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185(6):538-543.
6. van Hagen P., Hulshof M.C., van Lanschot J.J., et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012, 366(22):2074-2084.
7. Conroy T., Galais M.P., Raoul J.L., et al. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial. Lancet Oncol 2014, 15(3):305-314.
8. Gwynne S., Wijnhoven B.P.L., Hulshof M., Bateman A. Role of chemoradiotherapy in oesophageal cancer - adjuvant and neoadjuvant therapy. Clin Oncol 2014, 26.
9. Crosby T., Hurt C.N., Falk S., et al. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multi-centre phase 2/3 randomised trial. Lancet Oncol 2013, 14(7):627-637. 10.1016/S1470-2045(13)70136-0.
10. Rackley T., Leong T., Foo M., Crosby T. Definitive chemoradiotherapy for oesophageal cancer - a promising start on an exciting journey. Clin Oncol 2014, 26.
11. Foo M., Crosby T., Rackley T., Leong T. Role of (chemo)-radiotherapy in resectable gastric cancer. Clin Oncol 2014, 26.
12. Cunningham D., Alum W.H., Stenning S.P. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355(1):11-20.
13. Moutardier V., Magnin V., Turrini O., et al. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2004, 60(2):437-443.
14. Gillen S., Schuster T., Meyer Zum Büschenfelde C., Friess H., Kleeff J. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 2010, 7(4).
15. Iacobuzio-Donahue C.A., Fu B., Yachida S., et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 2009, 27(11):1806-1813.
16. Sen N., Falk S., Abrams R.A. Role of chemoradiotherapy in the adjuvant and neoadjuvant settings for resectable pancreatic cancer. Clin Oncol 2014, 26.
17. Huguet F., Mukherjee S., Javle M. Locally advanced pancreatic cancer: the role of definitive chemoradiatherapy. Clin Oncol 2014, 26.
18. Aitken K.L., Hawkins M.A. The role of radiotherapy and chemoradiation in the management of primary liver tumours. Clin Oncol 2014, 26.
19. Wilson J.M., Partridge M., Hawkins M. The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies. Clin Oncol 2014, 26.